Canadian expertise and achievements in regenerative medicine (RM) could be at a turning point if strategic steps are taken to increase stable funding and achieve greater coordination among the many federal and provincial players. Those are the key observations of a report issued by the Council of Canadian Academies (CCA), which was based on a two-day workshop held last October to provide policy makers with pointers for growing the sector and realizing greater economic and health benefits.